Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents

Brad W. Wilkins, Christiane Hesse, Hans P. Sviggum, Wayne T. Nicholson, Thomas P. Moyer, Michael Joseph Joyner, John H. Eisenach

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The ganglionic blocking agent trimethaphan (TMP) is no longer produced. Therefore, a need exists for alternative pharmacological approaches to investigate baroreflex control of the circulation. The aim of the present study was to examine baroreflex-mediated cardiovascular responses during the administration of a muscarinic receptor antagonist (glycopyrrolate; Gly) and a selective alpha-2 receptor agonist (dexmedetomidine; Dex) and to compare responses to ganglionic blockade with TMP. We hypothesized that combined Gly-Dex would inhibit the baroreflex similar to TMP. Ten volunteers participated in two study days and were instrumented with pulse oximeter, nasal cannula, ECG, continuous blood pressure monitoring (Finapres), and I.V. catheter for drug infusions. Each study day consisted of a control condition followed by either combined Gly-Dex or TMP on alternating days. A Valsalva maneuver was performed under each condition with every subject and six subjects received bolus phenylephrine (25 μg) during Gly-Dex and TMP. Combined Gly-Dex increased (P < 0.05) blood pressure (99 ± 4 mmHg) and heart rate (99 ± 3 bpm) relative to control condition (BP: 90 ± 2 mmHg; HR: 64 ± 3 bpm) and TMP infusion decreased (P < 0.05) blood pressure (79 ± 3 mmHg) while increasing heart rate (88 ± 3 bpm). Valsalva maneuver elicited a persistent drop in arterial pressure (no phase IIb recovery) with the absence of a phase IV overshoot during both Gly-Dex and TMP conditions. Phenylephrine increased systolic pressure 34 ± 4 mmHg under Gly-Dex and 23 ± 3 mmHg with TMP (P < 0.05). Heart rate only decreased 1 ± 2 bpm during Gly-Dex and 1 ± 1 bpm with TMP. Taken together, our results suggest that Gly-Dex is a reasonable alternative to TMP for baroreflex inhibition.

Original languageEnglish (US)
Pages (from-to)77-84
Number of pages8
JournalClinical Autonomic Research
Volume17
Issue number2
DOIs
StatePublished - Apr 2007

Fingerprint

Trimethaphan
Cholinergic Antagonists
Baroreflex
Blood Pressure
Valsalva Maneuver
Heart Rate
Phenylephrine
Ganglionic Blockers
Glycopyrrolate
Dexmedetomidine
Muscarinic Antagonists
Muscarinic Receptors
Pulse
Volunteers
Arterial Pressure
Electrocardiography
Catheters

Keywords

  • Autonomic nervous system
  • Blood pressure
  • Ganglionic blocking agents
  • Methodology
  • Valsalva's maneuver

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Wilkins, B. W., Hesse, C., Sviggum, H. P., Nicholson, W. T., Moyer, T. P., Joyner, M. J., & Eisenach, J. H. (2007). Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents. Clinical Autonomic Research, 17(2), 77-84. https://doi.org/10.1007/s10286-006-0387-7

Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents. / Wilkins, Brad W.; Hesse, Christiane; Sviggum, Hans P.; Nicholson, Wayne T.; Moyer, Thomas P.; Joyner, Michael Joseph; Eisenach, John H.

In: Clinical Autonomic Research, Vol. 17, No. 2, 04.2007, p. 77-84.

Research output: Contribution to journalArticle

Wilkins, BW, Hesse, C, Sviggum, HP, Nicholson, WT, Moyer, TP, Joyner, MJ & Eisenach, JH 2007, 'Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents', Clinical Autonomic Research, vol. 17, no. 2, pp. 77-84. https://doi.org/10.1007/s10286-006-0387-7
Wilkins, Brad W. ; Hesse, Christiane ; Sviggum, Hans P. ; Nicholson, Wayne T. ; Moyer, Thomas P. ; Joyner, Michael Joseph ; Eisenach, John H. / Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents. In: Clinical Autonomic Research. 2007 ; Vol. 17, No. 2. pp. 77-84.
@article{2186debec8a94376bd4d3bf7c6084938,
title = "Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents",
abstract = "The ganglionic blocking agent trimethaphan (TMP) is no longer produced. Therefore, a need exists for alternative pharmacological approaches to investigate baroreflex control of the circulation. The aim of the present study was to examine baroreflex-mediated cardiovascular responses during the administration of a muscarinic receptor antagonist (glycopyrrolate; Gly) and a selective alpha-2 receptor agonist (dexmedetomidine; Dex) and to compare responses to ganglionic blockade with TMP. We hypothesized that combined Gly-Dex would inhibit the baroreflex similar to TMP. Ten volunteers participated in two study days and were instrumented with pulse oximeter, nasal cannula, ECG, continuous blood pressure monitoring (Finapres), and I.V. catheter for drug infusions. Each study day consisted of a control condition followed by either combined Gly-Dex or TMP on alternating days. A Valsalva maneuver was performed under each condition with every subject and six subjects received bolus phenylephrine (25 μg) during Gly-Dex and TMP. Combined Gly-Dex increased (P < 0.05) blood pressure (99 ± 4 mmHg) and heart rate (99 ± 3 bpm) relative to control condition (BP: 90 ± 2 mmHg; HR: 64 ± 3 bpm) and TMP infusion decreased (P < 0.05) blood pressure (79 ± 3 mmHg) while increasing heart rate (88 ± 3 bpm). Valsalva maneuver elicited a persistent drop in arterial pressure (no phase IIb recovery) with the absence of a phase IV overshoot during both Gly-Dex and TMP conditions. Phenylephrine increased systolic pressure 34 ± 4 mmHg under Gly-Dex and 23 ± 3 mmHg with TMP (P < 0.05). Heart rate only decreased 1 ± 2 bpm during Gly-Dex and 1 ± 1 bpm with TMP. Taken together, our results suggest that Gly-Dex is a reasonable alternative to TMP for baroreflex inhibition.",
keywords = "Autonomic nervous system, Blood pressure, Ganglionic blocking agents, Methodology, Valsalva's maneuver",
author = "Wilkins, {Brad W.} and Christiane Hesse and Sviggum, {Hans P.} and Nicholson, {Wayne T.} and Moyer, {Thomas P.} and Joyner, {Michael Joseph} and Eisenach, {John H.}",
year = "2007",
month = "4",
doi = "10.1007/s10286-006-0387-7",
language = "English (US)",
volume = "17",
pages = "77--84",
journal = "Clinical Autonomic Research",
issn = "0959-9851",
publisher = "D. Steinkopff-Verlag",
number = "2",

}

TY - JOUR

T1 - Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents

AU - Wilkins, Brad W.

AU - Hesse, Christiane

AU - Sviggum, Hans P.

AU - Nicholson, Wayne T.

AU - Moyer, Thomas P.

AU - Joyner, Michael Joseph

AU - Eisenach, John H.

PY - 2007/4

Y1 - 2007/4

N2 - The ganglionic blocking agent trimethaphan (TMP) is no longer produced. Therefore, a need exists for alternative pharmacological approaches to investigate baroreflex control of the circulation. The aim of the present study was to examine baroreflex-mediated cardiovascular responses during the administration of a muscarinic receptor antagonist (glycopyrrolate; Gly) and a selective alpha-2 receptor agonist (dexmedetomidine; Dex) and to compare responses to ganglionic blockade with TMP. We hypothesized that combined Gly-Dex would inhibit the baroreflex similar to TMP. Ten volunteers participated in two study days and were instrumented with pulse oximeter, nasal cannula, ECG, continuous blood pressure monitoring (Finapres), and I.V. catheter for drug infusions. Each study day consisted of a control condition followed by either combined Gly-Dex or TMP on alternating days. A Valsalva maneuver was performed under each condition with every subject and six subjects received bolus phenylephrine (25 μg) during Gly-Dex and TMP. Combined Gly-Dex increased (P < 0.05) blood pressure (99 ± 4 mmHg) and heart rate (99 ± 3 bpm) relative to control condition (BP: 90 ± 2 mmHg; HR: 64 ± 3 bpm) and TMP infusion decreased (P < 0.05) blood pressure (79 ± 3 mmHg) while increasing heart rate (88 ± 3 bpm). Valsalva maneuver elicited a persistent drop in arterial pressure (no phase IIb recovery) with the absence of a phase IV overshoot during both Gly-Dex and TMP conditions. Phenylephrine increased systolic pressure 34 ± 4 mmHg under Gly-Dex and 23 ± 3 mmHg with TMP (P < 0.05). Heart rate only decreased 1 ± 2 bpm during Gly-Dex and 1 ± 1 bpm with TMP. Taken together, our results suggest that Gly-Dex is a reasonable alternative to TMP for baroreflex inhibition.

AB - The ganglionic blocking agent trimethaphan (TMP) is no longer produced. Therefore, a need exists for alternative pharmacological approaches to investigate baroreflex control of the circulation. The aim of the present study was to examine baroreflex-mediated cardiovascular responses during the administration of a muscarinic receptor antagonist (glycopyrrolate; Gly) and a selective alpha-2 receptor agonist (dexmedetomidine; Dex) and to compare responses to ganglionic blockade with TMP. We hypothesized that combined Gly-Dex would inhibit the baroreflex similar to TMP. Ten volunteers participated in two study days and were instrumented with pulse oximeter, nasal cannula, ECG, continuous blood pressure monitoring (Finapres), and I.V. catheter for drug infusions. Each study day consisted of a control condition followed by either combined Gly-Dex or TMP on alternating days. A Valsalva maneuver was performed under each condition with every subject and six subjects received bolus phenylephrine (25 μg) during Gly-Dex and TMP. Combined Gly-Dex increased (P < 0.05) blood pressure (99 ± 4 mmHg) and heart rate (99 ± 3 bpm) relative to control condition (BP: 90 ± 2 mmHg; HR: 64 ± 3 bpm) and TMP infusion decreased (P < 0.05) blood pressure (79 ± 3 mmHg) while increasing heart rate (88 ± 3 bpm). Valsalva maneuver elicited a persistent drop in arterial pressure (no phase IIb recovery) with the absence of a phase IV overshoot during both Gly-Dex and TMP conditions. Phenylephrine increased systolic pressure 34 ± 4 mmHg under Gly-Dex and 23 ± 3 mmHg with TMP (P < 0.05). Heart rate only decreased 1 ± 2 bpm during Gly-Dex and 1 ± 1 bpm with TMP. Taken together, our results suggest that Gly-Dex is a reasonable alternative to TMP for baroreflex inhibition.

KW - Autonomic nervous system

KW - Blood pressure

KW - Ganglionic blocking agents

KW - Methodology

KW - Valsalva's maneuver

UR - http://www.scopus.com/inward/record.url?scp=34247648081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247648081&partnerID=8YFLogxK

U2 - 10.1007/s10286-006-0387-7

DO - 10.1007/s10286-006-0387-7

M3 - Article

C2 - 17160588

AN - SCOPUS:34247648081

VL - 17

SP - 77

EP - 84

JO - Clinical Autonomic Research

JF - Clinical Autonomic Research

SN - 0959-9851

IS - 2

ER -